The most important financial indicators for the company Innopharma International Srl - Unique Identification Number 26893952:
sales in 2023 was
2.089
euro, registering a net profit of
-4.185
euro and having an average number of
employees.
Firma isi desfasoara activitatea in domeniul Cercetare-dezvoltare in alte stiinte naturale si inginerie having the NACE code 7219.
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded.
In the last year of activity, the sales decreased by -66.5%, from 6.256 euro in the year 2022, to 2.089 euro in 2023.
The Net Profit decreased by -39 euro, from 39 euro in 2022, to 0 in the last year.
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Innopharma International Srl - CUI 26893952
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Fixed Assets
2.375
2.196
1.976
1.829
585
574
563
550
552
550
Current Assets
17.619
25.177
62.019
27.284
19.251
15.944
18.718
12.613
13.273
15.624
Inventories
0
0
0
0
0
0
0
0
0
0
Receivables
15.443
23.454
61.640
26.347
17.492
15.944
18.674
12.592
13.076
13.486
Cash
2.176
1.723
378
937
1.759
0
44
21
197
2.138
Shareholders Funds
1.455
6.262
10.399
24.496
14.983
9.952
13.626
11.123
11.197
6.978
Social Capital
9.415
9.494
9.397
9.238
9.068
8.893
8.724
8.531
8.557
8.531
Debts
19.387
21.966
53.731
4.918
4.852
6.567
5.655
2.040
2.628
9.196
Income in Advance
0
0
40.448
0
0
0
0
0
0
0
Exchange rate - RON
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
4.4821
Main CAEN
"7219 - 7219"
CAEN Financial Year
7219
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
15.624 euro in 2023 which includes Inventories of
0 euro, Receivables of
13.486 euro and cash availability of
2.138 euro.
The company's Equity was valued at
6.978 euro, while total Liabilities amounted to
9.196 euro.
Equity decreased by -4.185 euro, from 11.197 euro in 2022, to 6.978 in 2023.
Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Innopharma International Srl